NovoCure Ltd. (NVCR)
NASDAQ
Closed
Oct 23, 2026
Day's Range
14.5352 wk Range
9.82Overview - NVCR - NovoCure Ltd.
Key Statistics
Valuation
Enterprise Value
1.50B
P/E (Trailing)
-12.01
P/E (Forward)
-18.20
PEG Ratio
0.18
Price / Sales (TTM)
2.44
Price / Book
5.05
EV / EBITDA
-11.01
Profitability
Gross Margin
77.60%
Profit Margin
-21.24%
Operating Margin
-5.75%
Return on Assets
-9.25%
Return on Equity
-43.21%
Ownership
Shares Outstanding
116.44M
Float
96.42M
Short % of Shares Outstanding
12.96%
Held by Insiders
9.95%
Held by Institutions
90.78%
Price stats
Beta
0.98
50-Day Avg
16.15
200-Day Avg
14.82
Dividends
Payout Ratio
0.00%
Analyst Consensus
7 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVCR - NovoCure Ltd.
Peers - NVCR - NovoCure Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- NVCRNASDAQNovoCure Ltd.1.70BMarket Cap+7.49%52-week change-12.02P/E (Trailing)-21.24%Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.32.50BMarket Cap-9.66%52-week change16.43P/E (Trailing)9.33%Profit Margin
- DXCMNASDAQDexCom Inc.32.44BMarket Cap+18.88%52-week change34.14P/E (Trailing)20.11%Profit Margin
- PODDNASDAQInsulet Corporation9.78BMarket Cap-131.64%52-week change26.42P/E (Trailing)12.29%Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.37%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corp.8.77BMarket Cap+32.91%52-week change74.88P/E (Trailing)-2.03%Profit Margin
- LIVNNASDAQLivaNova PLC4.45BMarket Cap+32.91%52-week change23.93P/E (Trailing)12.81%Profit Margin
Profile Summary - NVCR - NovoCure Ltd.
About
NovoCure Ltd. is a global oncology company focused on developing and commercializing Tumor Treating Fields, a non-invasive cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cell division. Its current commercial portfolio includes Optune Gio for glioblastoma and Optune Lua…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
